[go: up one dir, main page]

AU2002226690A1 - Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases - Google Patents

Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases

Info

Publication number
AU2002226690A1
AU2002226690A1 AU2002226690A AU2002226690A AU2002226690A1 AU 2002226690 A1 AU2002226690 A1 AU 2002226690A1 AU 2002226690 A AU2002226690 A AU 2002226690A AU 2002226690 A AU2002226690 A AU 2002226690A AU 2002226690 A1 AU2002226690 A1 AU 2002226690A1
Authority
AU
Australia
Prior art keywords
diagnosis
drugs
tissue
treatment
proliferative diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002226690A
Other versions
AU2002226690B2 (en
Inventor
Akio Hayashi
Jun Toyohara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Priority claimed from PCT/JP2002/000408 external-priority patent/WO2002058740A1/en
Publication of AU2002226690A1 publication Critical patent/AU2002226690A1/en
Application granted granted Critical
Publication of AU2002226690B2 publication Critical patent/AU2002226690B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002226690A 2001-01-23 2002-01-22 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases Ceased AU2002226690B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001014954 2001-01-23
JP2001-14954 2001-01-23
PCT/JP2002/000408 WO2002058740A1 (en) 2001-01-23 2002-01-22 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
AU2002226690A1 true AU2002226690A1 (en) 2003-02-06
AU2002226690B2 AU2002226690B2 (en) 2006-07-13

Family

ID=18881578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226690A Ceased AU2002226690B2 (en) 2001-01-23 2002-01-22 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases

Country Status (13)

Country Link
US (2) US7045115B2 (en)
EP (1) EP1270017B1 (en)
JP (1) JP4210118B2 (en)
KR (1) KR100867729B1 (en)
CN (1) CN100400107C (en)
AT (1) ATE322912T1 (en)
AU (1) AU2002226690B2 (en)
CA (1) CA2402991C (en)
DE (1) DE60210538T2 (en)
NO (1) NO328812B1 (en)
NZ (1) NZ520934A (en)
TW (1) TWI247609B (en)
WO (1) WO2002058740A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
EP1673353A4 (en) * 2003-09-05 2007-03-28 Einstein Coll Med TRANSITION STATE STRUCTURE AND INHIBITORS OF THYMIDINE PHOSPHORYLASES
CA2538252C (en) * 2003-09-18 2014-02-25 Isis Pharmaceuticals, Inc. 4'-thionucleosides and oligomeric compounds
US7485283B2 (en) * 2004-04-28 2009-02-03 Lantheus Medical Imaging Contrast agents for myocardial perfusion imaging
JP4841231B2 (en) * 2005-11-07 2011-12-21 日本メジフィジックス株式会社 Tissue proliferative diagnostic agent
US20070274908A1 (en) * 2006-04-07 2007-11-29 The Board Of Regents Of The University Of Texas System Methods and compositions related to adenoassociated virus-phage particles
US7928210B2 (en) 2007-03-01 2011-04-19 Siemens Medical Solutions Usa, Inc. Nucleoside based proliferation imaging markers
WO2008124197A1 (en) * 2007-04-10 2008-10-16 The Johns Hopkins University Imaging and therapy of virus-associated tumors
JP5946992B2 (en) * 2008-02-29 2016-07-06 ランセウス メディカル イメージング, インコーポレイテッド Contrast agents for applications involving perfusion imaging
GB0815831D0 (en) * 2008-09-01 2008-10-08 Imp Innovations Ltd Compounds
DK2419096T3 (en) 2009-04-15 2020-02-03 Lantheus Medical Imaging Inc STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID
CA2789044C (en) 2010-02-08 2020-09-15 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof
US8835612B2 (en) * 2010-10-09 2014-09-16 Fabio Polato Isolation of phosphoproteins, glycoproteins and fragments thereof
JP5794521B2 (en) * 2011-03-29 2015-10-14 国立大学法人福井大学 Apoptosis inducer
BR112014020416B1 (en) 2012-03-28 2022-03-29 Fujifilm Corporation 1-(2-deoxy-2-fluor-4-thio-ß-darabinofuranosyl) cytosine crystal and pharmaceutical composition containing said crystal
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
TWI603966B (en) 2012-08-13 2017-11-01 富士軟片股份有限公司 Synthesis intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthesis intermediate of thionucleoside and manufacturing method thereof
JP2014062054A (en) * 2012-09-20 2014-04-10 Gyoseiin Genshino Iinkai Kakuno Kenkyusho Probe of iodine-123 marker thymine analogue [123i]-iarau
JP6351107B2 (en) * 2014-02-18 2018-07-04 富士フイルム株式会社 Method for producing thiolane skeleton type sugar compound and thiolane skeleton type sugar compound
TWI678373B (en) 2014-10-31 2019-12-01 日商富士軟片股份有限公司 Thionucleoside derivative or its salt and pharmaceutical composition
MX392665B (en) 2016-08-31 2025-03-24 Fujifilm Corp ANTITUMORAL AGENT, ANTITUMORAL EFFECT ENHANCER, AND ANTITUMORAL KIT.
MX2018002611A (en) 2018-01-29 2019-07-30 Fujifilm Corp Antitumor agent for biliary cancer and treatment method of biliary cancer.
CN113683648B (en) * 2021-08-26 2025-03-07 上海皓鸿生物医药科技有限公司 A synthetic method of 2'-fluoro-2'-deoxyuridine and its intermediate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides
US5077034A (en) * 1990-03-30 1991-12-31 The President And Fellows Of Harvard College Treatment of tumors with 5-radioiodo-2'-deoxyuridine
US5248771A (en) * 1991-06-26 1993-09-28 Triumf Process for preparing no-carrier-added radiohalogenated vinyl nucleosides
GB9421223D0 (en) 1994-10-21 1994-12-07 Univ Alberta Tissue imaging in gene therapy
US5574148A (en) 1995-02-02 1996-11-12 President U Fellows Of Harvard College Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides
US5703056A (en) 1995-03-15 1997-12-30 Sloan-Kettering Institute For Cancer Research Non-invasive imaging of gene transfer
US5720935A (en) * 1995-06-09 1998-02-24 President & Fellows Of Harvard College Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides from stannyl precursors
WO1996041646A2 (en) 1995-06-13 1996-12-27 Dyer, Alison, Margaret Pharmaceutical compositions containing lornoxicam and cyclodextrin
US6331287B1 (en) 1995-08-23 2001-12-18 University Advanced Bio-Imaging Associates 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside
WO2001005439A1 (en) * 1999-07-14 2001-01-25 President And Fellows Of Harvard College Radiodetection and therapy of aberrant cell proliferation
KR200188038Y1 (en) 2000-01-24 2000-07-15 이정진 Hand phone for electron pulse

Similar Documents

Publication Publication Date Title
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2003239531A1 (en) Protein cages for the delivery of medical imaging and therapy
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AU2003263628A1 (en) Medical treatment system for stimulating spots on the body suitable for acupuncture
AU2003299378A1 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2003209150A1 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
AU2002246151A1 (en) Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2003263036A1 (en) SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
GB0212790D0 (en) Medicament for the treatment of diabetes
AU2002344959A1 (en) Use of fasl for the treatment of neurodegenerative diseases
AU2002365654A1 (en) Treatment of diseases via the skin
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors